Literature DB >> 21352207

Infections and immunodeficiency in Down syndrome.

G Ram1, J Chinen.   

Abstract

Down syndrome (DS) is the most common genetic disease and presents with cognitive impairment, cardiac and gastrointestinal abnormalities, in addition to other miscellaneous clinical conditions. DS individuals may have a high frequency of infections, usually of the upper respiratory tract, characterized by increased severity and prolonged course of disease, which are partially attributed to defects of the immune system. The abnormalities of the immune system associated with DS include: mild to moderate T and B cell lymphopenia, with marked decrease of naive lymphocytes, impaired mitogen-induced T cell proliferation, reduced specific antibody responses to immunizations and defects of neutrophil chemotaxis. Limited evidence of genetic abnormalities secondary to trisomy of chromosome 21 and affecting the immune system is available, such as the potential consequences of gene over-expression, most significantly SOD1 and RCAN1. Secondary immunodeficiency due to metabolic or nutritional factors in DS, particularly zinc deficiency, has been postulated. Non-immunological factors, including abnormal anatomical structures (e.g. small ear canal, tracheomalacia) and gastro-oesophageal reflux, may play a role in the increased frequency of respiratory tract infections. The molecular mechanisms leading to the immune defects observed in DS individuals and the contribution of these immunological abnormalities to the increased risk of infections require further investigation. Addressing immunological and non-immunological factors involved in the pathogenesis of infectious diseases may reduce the susceptibility to infections in DS subjects.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Year:  2011        PMID: 21352207      PMCID: PMC3074212          DOI: 10.1111/j.1365-2249.2011.04335.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  83 in total

1.  Defective antibody response to bacteriophage phichi 174 in Down syndrome.

Authors:  V Lopez; H D Ochs; H C Thuline; S D Davis; R J Wedgwood
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

2.  Intrinsic abnormalities of lymphocyte counts in children with down syndrome.

Authors:  Yvette C M de Hingh; Petrus W van der Vossen; Eugenie F A Gemen; André B Mulder; Wim C J Hop; Frank Brus; Esther de Vries
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

3.  Down syndrome: patterns of disturbed lung growth.

Authors:  B L Schloo; G F Vawter; L M Reid
Journal:  Hum Pathol       Date:  1991-09       Impact factor: 3.466

4.  Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers.

Authors:  A Cossarizza; D Monti; G Montagnani; C Ortolani; M Masi; M Zannotti; C Franceschi
Journal:  Am J Med Genet Suppl       Date:  1990

5.  Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients.

Authors:  B T Costa-Carvalho; R M A Martinez; A T N Dias; C A Kubo; P Barros-Nunes; L Leiva; D Solé; M M S Carneiro-Sampaio; C K Naspitz; R U Sorensen
Journal:  Braz J Med Biol Res       Date:  2006-12       Impact factor: 2.590

6.  Prevalence of positive skin prick test results in children with Down syndrome: a case-control study.

Authors:  Susan E Mannan; Ejaz Yousef; Jobayer Hossain
Journal:  Ann Allergy Asthma Immunol       Date:  2009-03       Impact factor: 6.347

7.  Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes.

Authors:  Maaike A A Kusters; Eugenie F A Gemen; Ruud H J Verstegen; Peter C Wever; Esther DE Vries
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

8.  Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study.

Authors:  Beatrijs L P Bloemers; A Marceline van Furth; Michel E Weijerman; Reinoud J B J Gemke; Chantal J M Broers; Kimberly van den Ende; Jan L L Kimpen; Jan L M Strengers; Louis J Bont
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

9.  Obstructive sleep apnea in children with Down syndrome.

Authors:  C L Marcus; T G Keens; D B Bautista; W S von Pechmann; S L Ward
Journal:  Pediatrics       Date:  1991-07       Impact factor: 7.124

10.  Upper airway obstruction in children with Down syndrome.

Authors:  I N Jacobs; R F Gray; N W Todd
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-09
View more
  110 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Neonatal screening for severe combined immunodeficiency.

Authors:  Jennifer M Puck
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

3.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.

Authors:  Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2012-01-29       Impact factor: 10.793

Review 4.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

5.  Down syndrome and microRNAs.

Authors:  Aldina Brás; António S Rodrigues; Bruno Gomes; José Rueff
Journal:  Biomed Rep       Date:  2017-11-17

Review 6.  Demodex species in human ocular disease: new clinicopathological aspects.

Authors:  Stephen G Nicholls; Carmen L Oakley; Andrea Tan; Brendan J Vote
Journal:  Int Ophthalmol       Date:  2016-05-09       Impact factor: 2.031

7.  Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation.

Authors:  Sonja M Sachse; Sam Lievens; Luís F Ribeiro; Dan Dascenco; Delphine Masschaele; Katrien Horré; Anke Misbaer; Nele Vanderroost; Anne Sophie De Smet; Evgenia Salta; Maria-Luise Erfurth; Yoshiaki Kise; Siegfried Nebel; Wouter Van Delm; Stéphane Plaisance; Jan Tavernier; Bart De Strooper; Joris De Wit; Dietmar Schmucker
Journal:  EMBO J       Date:  2019-02-11       Impact factor: 11.598

8.  Surgical Treatment for Congenital Heart Defects in Down Syndrome Patients.

Authors:  Fernando Cesar Gimenes Barbosa Santos; Ulisses Alexandre Croti; Carlos Henrique De Marchi; Alexandre Noboru Murakami; Juliana Dane Pereira Brachine; Bruna Cury Borim; Renata Geron Finoti; Moacir Fernandes de Godoy
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

9.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

10.  Neonatal sepsis and multiple skin abscess in a newborn with Down's syndrome: A case report.

Authors:  Arunava Kali; Umadevi Sivaraman; Srirangaraj Sreenivasan; Selvaraj Stephen
Journal:  Australas Med J       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.